Competitive and allosteric interactions in ligand binding to P-glycoprotein as observed on an immobilized P-glycoprotein liquid chromatographic stationary phase

被引:30
作者
Lu, LL
Leonessa, F
Clarke, R
Wainer, IW
机构
[1] Georgetown Univ, Sch Med, Dept Pharmacol, Washington, DC 20007 USA
[2] Georgetown Univ, Sch Med, Vincent T Lombardi Canc Res Ctr, Washington, DC 20007 USA
关键词
D O I
10.1124/mol.59.1.62
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
A liquid chromatographic stationary phase containing immobilized P-glycoprotein (Pgp) was synthesized using cell membranes obtained from Pgp-expressing cells. The resulting Pgp-stationary phase was used in frontal and zonal chromatographic studies to investigate the binding of vinblastine (VBL), doxorubicin (DOX), verapamil (VER), and cyclosporin A (CsA) to the immobilized Pgp. The compounds were added individually to the chromatographic system with or without ATP in the running buffer. Using this approach, dissociation constants were calculated for VBL (23.5 +/- 7.8 nM), DOX (15.0 +/- 3.2 muM), VER (54.2 +/- 4.7 muM), and CsA [97.9 +/- 19.4 nM (without ATP) and 62.5 +/- 4.6 nM (with ATP)]. The compounds were also added in pairs using standard competitive chromatography procedures. The results of the study demonstrate that competitive interactions occurred between VBL and DOX, cooperative allosteric interactions occurred between VBL and CsA and ATP and CsA, and anticooperative allosteric interactions occurred between ATP and VBL and VER. The chromatographic studies indicate that the immobilized Pgp was modified by ligand and cofactor binding and that the stationary phase can be used to study drug-drug binding interactions on the Pgp molecule.
引用
收藏
页码:62 / 68
页数:7
相关论文
共 40 条
[1]   Steroid transport, accumulation, and antagonism of P-glycoprotein in multidrug-resistant cells [J].
Barnes, KM ;
Dickstein, B ;
Cutler, GB ;
Fojo, T ;
Bates, SE .
BIOCHEMISTRY, 1996, 35 (15) :4820-4827
[2]   Immobilized membrane vesicle or proteoliposome affinity chromatography. Frontal analysis of interactions of cytochalasin B and D-glucose with the human red cell glucose transporter [J].
Brekkan, E ;
Lundqvist, A ;
Lundahl, P .
BIOCHEMISTRY, 1996, 35 (37) :12141-12145
[3]   The functional purification of P-glycoprotein is dependent on maintenance of a lipid-protein interface [J].
Callaghan, R ;
Berridge, G ;
Ferry, DR ;
Higgins, CF .
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES, 1997, 1328 (02) :109-124
[4]   HORMONE RESISTANCE, INVASIVENESS, AND METASTATIC POTENTIAL IN BREAST-CANCER [J].
CLARKE, R ;
THOMPSON, EW ;
LEONESSA, F ;
LIPPMAN, J ;
MCGARVEY, M ;
FRANDSEN, TL ;
BRUNNER, N .
BREAST CANCER RESEARCH AND TREATMENT, 1993, 24 (03) :227-239
[5]  
CLARKE R, 1994, DRUG HORMONAL RESIST, P407
[6]   MULTIDRUG-RESISTANCE GENE (P-GLYCOPROTEIN) IS EXPRESSED BY ENDOTHELIAL-CELLS AT BLOOD-BRAIN BARRIER SITES [J].
CORDONCARDO, C ;
OBRIEN, JP ;
CASALS, D ;
RITTMANGRAUER, L ;
BIEDLER, JL ;
MELAMED, MR ;
BERTINO, JR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (02) :695-698
[7]   AMINO-ACID SUBSTITUTIONS IN THE 6TH TRANSMEMBRANE DOMAIN OF P-GLYCOPROTEIN ALTER MULTIDRUG RESISTANCE [J].
DEVINE, SE ;
LING, V ;
MELERA, PW .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (10) :4564-4568
[8]   Evidence for two nonidentical drug-interaction sites in the human P-glycoprotein [J].
Dey, S ;
Ramachandra, M ;
Pastan, I ;
Gottesman, MM ;
Ambudkar, SV .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (20) :10594-10599
[9]  
Döppenschmitt S, 1999, J PHARMACOL EXP THER, V288, P348
[10]   A multidrug resistance transporter from human MCF-7 breast cancer cells [J].
Doyle, LA ;
Yang, WD ;
Abruzzo, LV ;
Krogmann, T ;
Gao, YM ;
Rishi, AK ;
Ross, DD .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (26) :15665-15670